Epstein-Barr virus EBNA2 blocks Nur77-mediated apoptosis

被引:67
作者
Lee, JM
Lee, KH
Weidner, M
Osborne, BA
Hayward, SD
机构
[1] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Bunting Blaustein Bldg CRB308, Baltimore, MD 21231 USA
[2] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21231 USA
[3] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA
关键词
D O I
10.1073/pnas.182552499
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epstein-Barr virus infection in vitro immortalizes primary 8 cells. EBNA2 is an Epstein-Barr virus-encoded transcriptional transactivator that mimics the effects of activated Notch signaling and is essential for this proliferative response. An assay using Sindbis virus (SV) as a cell death inducer revealed that, like Notch, EBNA2 also has antiapoptotic activity. We show that Nur77 is a mediator of SV-induced cell death and that EBNA2 antiapoptotic activity results from interaction with Nur77. EBNA2 colocalized with Nur77 in transfected cells and coprecipitated with Nur77 in IB4 B cells. EBNA2 binds to Nur77 through sequences in the EBNA2 amino acid 123-147 conserved domain and an EBNA2 mutant unable to bind Nur77 also lost the ability to protect cells from SV-induced apoptosis. EBNA2 exerted its antideath function by retaining Nur77 in the nucleus and preventing Nur77 from targeting mitochondria in response to apoptotic stimuli. Thus, targeting of Nur77 can be added to the list of strategies used by viruses to counter apoptosis.
引用
收藏
页码:11878 / 11883
页数:6
相关论文
共 77 条
[1]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[2]   PRIMARY CENTRAL-NERVOUS-SYSTEM MALIGNANT NON-HODGKINS-LYMPHOMAS FROM HIV-INFECTED AND NONINFECTED PATIENTS - EXPRESSION OF CELLULAR-SURFACE PROTEINS AND EPSTEIN-BARR VIRAL MARKERS [J].
AUPERIN, I ;
MIKOL, J ;
OKSENHENDLER, E ;
THIEBAUT, JB ;
BRUNET, M ;
DUPONT, B ;
MORINET, F .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1994, 20 (03) :243-252
[3]   Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins [J].
Bellows, DS ;
Chau, BN ;
Lee, P ;
Lazebnik, Y ;
Burns, WH ;
Hardwick, JM .
JOURNAL OF VIROLOGY, 2000, 74 (11) :5024-5031
[4]   NF-κB inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells [J].
Cahir-McFarland, ED ;
Davidson, DM ;
Schauer, SL ;
Duong, J ;
Kieff, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :6055-6060
[5]  
CALNAN BJ, 1995, IMMUNITY, V3, P273
[6]  
CEN H, 1993, BLOOD, V81, P1393
[7]   Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood [J].
Chen, HL ;
Smith, P ;
Ambinder, RF ;
Hayward, SD .
BLOOD, 1999, 93 (09) :3026-3032
[8]   Bax-independent inhibition of apoptosis by Bcl-x(L) [J].
Cheng, EHY ;
Levine, B ;
Boise, LH ;
Thompson, CB ;
Hardwick, JM .
NATURE, 1996, 379 (6565) :554-556
[9]   Modulation of cell death by Bcl-xL through caspase interaction [J].
Clem, RJ ;
Cheng, EHY ;
Karp, CL ;
Kirsch, DG ;
Ueno, K ;
Takahashi, A ;
Kastan, MB ;
Griffin, DE ;
Earnshaw, WC ;
Veliuona, MA ;
Hardwick, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :554-559
[10]   EPSTEIN-BARR-VIRUS NUCLEAR PROTEIN-2 MUTATIONS DEFINE ESSENTIAL DOMAINS FOR TRANSFORMATION AND TRANSACTIVATION [J].
COHEN, JI ;
WANG, F ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1991, 65 (05) :2545-2554